Literature DB >> 23677541

[Bullous autoimmune disorders in children].

M Sárdy1, M Kasperkiewicz.   

Abstract

We review the pathogenesis, clinical features, diagnosis, differential diagnosis, and therapy of autoimmune bullous skin diseases of childhood, especially of the most common linear IgA dermatosis. In autoimmune bullous diseases, autoantibodies are formed against different adhesion molecules of the skin. These are not only pathophysiologically relevant, but also serve as basis for diagnosis and follow-up of these diseases. In case an autoimmune bullous disease is suspected, histopathology and immunohistopathology (direct immunofluorescence microscopy) as well as serological tests (indirect immunofluorescence microscopy, ELISA, immunoblot) should be performed. Therapy depends on the diagnosis. In IgA-mediated pathogenesis, dapsone can be successfully used. In IgG-mediated diseases, immunosuppression with corticosteroids and steroid-sparing agents should be initiated, although only local therapy is sufficient to control a self-limiting pemphigus neonatorum. In dermatitis herpetiformis, a life-long gluten-free diet is recommended.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23677541     DOI: 10.1007/s00105-013-2536-y

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   0.751


  9 in total

1.  Chronic bullous dermatosis of childhood associated with coeliac disease in a 6-year-old boy.

Authors:  Lotta Högberg; Jan Sokolski; Lars Stenhammar
Journal:  Acta Derm Venereol       Date:  2004       Impact factor: 4.437

Review 2.  Autoimmune bullous diseases in childhood.

Authors:  Freda Sansaricq; Sarah L Stein; Vesna Petronic-Rosic
Journal:  Clin Dermatol       Date:  2012 Jan-Feb       Impact factor: 3.541

Review 3.  Autoimmune bullous skin diseases. Part 1: Clinical manifestations.

Authors:  Andrea Kneisel; Michael Hertl
Journal:  J Dtsch Dermatol Ges       Date:  2011-10       Impact factor: 5.584

Review 4.  [Dermatitis herpetiformis. An update of the pathogenesis].

Authors:  M Sárdy; J Tietze
Journal:  Hautarzt       Date:  2009-08       Impact factor: 0.751

Review 5.  The diagnosis and treatment of autoimmune blistering skin diseases.

Authors:  Enno Schmidt; Detlef Zillikens
Journal:  Dtsch Arztebl Int       Date:  2011-06-10       Impact factor: 5.594

Review 6.  Survivin: a dual player in healthy and diseased skin.

Authors:  Katiuscia Dallaglio; Alessandra Marconi; Carlo Pincelli
Journal:  J Invest Dermatol       Date:  2011-09-08       Impact factor: 8.551

Review 7.  Autoimmune bullous skin diseases. Part 2: diagnosis and therapy.

Authors:  Andrea Kneisel; Michael Hertl
Journal:  J Dtsch Dermatol Ges       Date:  2011-11       Impact factor: 5.584

Review 8.  Linear IgA disease: successful application of immunoadsorption and review of the literature.

Authors:  Michael Kasperkiewicz; Markus Meier; Detlef Zillikens; Enno Schmidt
Journal:  Dermatology       Date:  2010-02-03       Impact factor: 5.366

9.  [Blistering autoimmune diseases of childhood].

Authors:  M Goebeler; D Zillikens
Journal:  Hautarzt       Date:  2002-12-20       Impact factor: 0.751

  9 in total
  4 in total

Review 1.  [Pemphigus. Model disease for targeted therapy].

Authors:  R Eming
Journal:  Hautarzt       Date:  2015-08       Impact factor: 0.751

2.  [Pediatric linear IgA/IgG dermatosis].

Authors:  Orsolya N Horváth; Tanja von Braunmühl; Miklós Sárdy
Journal:  Hautarzt       Date:  2018-10       Impact factor: 0.751

3.  [Differential diagnosis of oral mucosal erosions and ulcers in children].

Authors:  S Benoit; H Hamm
Journal:  Hautarzt       Date:  2015-04       Impact factor: 0.751

Review 4.  [Pemphigoid diseases. Autoimmune diseases in the elderly].

Authors:  O N Horváth; J Jankásková; A Walker; M Sárdy
Journal:  Hautarzt       Date:  2015-08       Impact factor: 0.751

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.